Melville, NY-based Ellen Scharaga functions as an operational consultant who helps Alegria Specialty Pharmacy develop medical compounds for treating a wide variety of chronic ailments. Her assistance has resulted in, among other things, faster turnaround times for filling prescriptions. In addition to her career, Ellen Scharaga gives to charitable causes, including the Alzheimer’s Foundation of America.
Alzheimer’s disease is a progressive, degenerative form of dementia that affects over 5 million people in the U.S. The risk of developing the disease doubles every five years for people aged 65 and older. Additionally, about 500,000 people younger than 65 have early-onset forms of dementia, which includes Alzheimer’s disease. The disease attacks the neurons in the brain, leading to memory loss, a breakdown of language and thought processing, and changes in behavior. Short-term memory first begins to break down when nerve cells of the hippocampus are destroyed, and when neurons in the cerebral cortex are targeted, other functions like language and behavior are impacted. For more information on this disease, visit www.alzfdn.org.
0 Comments
Leave a Reply. |